The antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease and increases hepatic pyruvate dehydrogenase activity
Rami Al Batran(Université de Montréal), John R. Ussher(University of Alberta)
Cited by 18
Related Papers
Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency
|Cardiovascular Research|2019|195
GIPR Is Predominantly Localized to Nonadipocyte Cell Types Within White Adipose Tissue
|Diabetes|2022|62
Cardiac-Specific Deletion of Pyruvate Dehydrogenase Impairs Glucose Oxidation Rates and Induces Diastolic Dysfunction
|Frontiers in Cardiovascular Medicine|2018|42
Ketone ester administration improves glycemia in obese mice
|American Journal of Physiology-Cell Physiology|2023|18